Understanding Hypersensitivity Reactions: An MRCEM Primary Revision Guide to Anaphylaxis and Immune Pathology

If you are working through your MRCEM Primary pathology revision, few topics reward careful study as richly as hypersensitivity reactions and the immune responses that underpin them. Questions on anaphylaxis, adaptive immunity, and immune-mediated pathology appear regularly in the MRCEM Primary exam, and a solid conceptual framework will help you tackle both straightforward recall questions and the more challenging applied SBA stems you will encounter on exam day. This guide walks through the core science in a clinically grounded way, so you can connect the basic immunology to what you already see in the emergency department.

What is the Adaptive Immune Response, and Why Does it Matter for MRCEM Primary Pathology Revision?

The adaptive immune system is the branch of immunity that is antigen-specific, develops over days rather than minutes, and — crucially — retains immunological memory. It is built around two major lymphocyte lineages:

• T lymphocytes — responsible for cell-mediated immunity, maturing in the thymus after arising from haematopoietic stem cells in the bone marrow.
• B lymphocytes — responsible for humoral immunity, maturing in the bone marrow before migrating to secondary lymphoid organs such as lymph nodes and the spleen.

Understanding the distinction between these lineages is not just academic. In the ED, a patient’s immunological history — whether they have encountered a pathogen before, whether they are vaccinated, or whether their adaptive immune system is compromised — directly determines the clinical presentation and trajectory. The MRCEM Primary exam frequently tests these principles in scenario-based questions.

Key Cell Types You Need to Know

• CD4+ T helper cells — orchestrate the broader immune response by releasing cytokines that activate both B cells and cytotoxic T cells.
• CD8+ cytotoxic T cells — destroy virally infected cells and tumour cells via perforin and granzyme pathways.
• B lymphocytes and plasma cells — B cells differentiate into plasma cells, which secrete large quantities of antigen-specific immunoglobulin.
• Memory T and B cells — long-lived cells that persist after the primary response and enable the rapid, amplified secondary response on re-exposure.
• Antigen-presenting cells (APCs) — dendritic cells, macrophages, and B cells that process antigen and present it on MHC molecules. MHC class II presents to CD4+ T cells; MHC class I presents to CD8+ T cells.

How Does the Primary Immune Response Differ from the Secondary Response?

This comparison is a classic MRCEM SBA revision topic and one that lends itself well to single best answer question formats. The two responses differ in speed, magnitude, antibody class, and clinical consequence.

The Primary Immune Response

When the body encounters a novel antigen for the first time, naive lymphocytes must be identified, activated, and clonally expanded before an effective defence can be mounted. This takes approximately 10 to 14 days. The sequence runs broadly as follows:

1. Antigen is captured by APCs — chiefly dendritic cells — at the site of entry.
2. APCs migrate to the draining lymph node and present antigen peptides on MHC class II to naive CD4+ T helper cells.
3. Full T-cell activation requires co-stimulatory signals: CD80/86 on the APC must bind CD28 on the T cell. Without this second signal, the T cell becomes anergic rather than activated — a key tolerogenic mechanism.
4. Activated CD4+ T cells release IL-2 and other cytokines, driving clonal expansion of both T and B lymphocytes.
5. B cells in germinal centres of lymph nodes undergo somatic hypermutation (refining antibody affinity) and class switching (moving from IgM to IgG, IgA, or IgE production).
6. The dominant antibody produced early is IgM, with later class switching to IgG.

The primary response is of lower magnitude and shorter duration than subsequent responses. This is why first-time infections — or first exposures to allergens — tend to cause a less violent immunological reaction than repeat exposures.

The Secondary Immune Response

On re-exposure to the same antigen, pre-formed memory B and T cells are rapidly recruited. The response is faster (days rather than weeks), of greater magnitude, predominantly IgG-mediated, and more sustained. This is the scientific basis for vaccination and for the clinical phenomenon of more severe allergic reactions on repeat allergen exposure.

What are Hypersensitivity Reactions, and How are They Classified?

The Gell and Coombs classification divides hypersensitivity reactions into four types. This framework is tested directly in MRCEM Primary exam questions and is essential MRCEM Primary pathology revision material.

Type I — Immediate (IgE-Mediated) Hypersensitivity

This is the mechanism behind anaphylaxis, allergic asthma, urticaria, and allergic rhinitis. On first exposure to an allergen, IgE antibodies are produced and bind to the surface of mast cells and basophils via high-affinity Fc receptors. On re-exposure, the allergen cross-links these surface-bound IgE molecules, triggering rapid degranulation and release of histamine, tryptase, leukotrienes, and prostaglandins. The result is vasodilation, increased vascular permeability, bronchospasm, and mucus hypersecretion — the hallmarks of an anaphylactic response.

In the emergency department, understanding this mechanism informs immediate management: adrenaline reverses vasodilation and bronchospasm, antihistamines block histamine receptors, and steroids dampen the late-phase inflammatory response driven by prostaglandins and leukotrienes.

Type II — Cytotoxic (Antibody-Mediated) Hypersensitivity

IgG or IgM antibodies bind to antigens on the surface of host cells, leading to complement activation and cell destruction. Clinically relevant examples include haemolytic transfusion reactions, Goodpasture syndrome, and some drug-induced haemolytic anaemias. These scenarios appear in FRCEM SBA clinical scenarios and MRCEM SBA trauma and critical care questions.

Type III — Immune Complex-Mediated Hypersensitivity

Antigen-antibody complexes are deposited in tissues and trigger complement activation, neutrophil recruitment, and local inflammation. Examples include serum sickness, post-streptococcal glomerulonephritis, and systemic lupus erythematosus. The 10 to 21-day time course after the precipitating event is a useful distinguishing feature in SBA stems.

Type IV — Delayed (Cell-Mediated) Hypersensitivity

Unlike the other types, Type IV does not involve antibodies. Instead, sensitised CD4+ T helper cells (particularly Th1 cells) recognise antigen and release cytokines that recruit and activate macrophages, causing tissue damage over 48 to 72 hours. The tuberculin skin test, contact dermatitis, and granuloma formation in tuberculosis are the classic examples. This mechanism also underlies transplant rejection and some drug reactions.

How is Anaphylaxis Pathophysiology Tested in the MRCEM Primary Exam?

Anaphylaxis questions in the MRCEM Primary exam often blend basic science with clinical management, so understanding the underlying immunology strengthens your ability to reason through the stems. Common question themes include:

• Which immunoglobulin class mediates the initial sensitisation phase in Type I hypersensitivity?
• Which cells carry preformed IgE on their surface prior to re-exposure?
• What is the mechanism of action of adrenaline in anaphylaxis, and why is it first-line?
• What distinguishes anaphylaxis from an anaphylactoid reaction at the cellular level?
• What laboratory marker is useful in confirming mast cell degranulation retrospectively?

For the last point: serum tryptase, released from mast cell granules, peaks at one to two hours after the trigger and can be measured to support a diagnosis of anaphylaxis. It is an important detail for both MRCEM SBA exam questions and real clinical practice.

Practical Revision Tips for MRCEM Primary Pathology Revision on Immunology

Immunology can feel abstract, but anchoring the concepts to clinical scenarios makes them stick. Here are strategies that work well for MRCEM Primary online revision:

• Use the Gell-Coombs types as a framework — when you see any immune-mediated condition in a question stem, classify it immediately. This narrows your differential for the mechanism being asked about.
• Learn the antibody classes and their functions — IgM is the first responder, IgG is the most abundant and crosses the placenta, IgA is secretory, IgE mediates allergy. These distinctions come up repeatedly in MRCEM Primary MCQs.
• Practise the kinetics — primary response at 10 to 14 days, Type III reactions at 10 to 21 days, Type IV reactions at 48 to 72 hours. Timelines are a favourite discriminator in SBA question design.
• Connect basic science to ED presentations — transfusion reactions, anaphylaxis, contact dermatitis, and post-infectious complications all map onto the hypersensitivity types. Using clinical anchors improves retention significantly.
• Work through MRCEM Primary practice questions regularly rather than reading alone — active recall testing is the most evidence-based revision strategy available.

How EM Learning Centre Supports Your Revision

EM Learning Centre is built specifically for emergency medicine trainees preparing for the MRCEM Primary and MRCEM SBA exams. The platform offers structured question banks, detailed explanations mapped to the exam syllabus, and revision notes covering pathology, physiology, pharmacology, anatomy, and more — all written by emergency medicine educators who understand exactly what the examiners are looking for.

Whether you are just starting your preparation or in the final weeks before your exam date, working through high-quality, exam-focused questions is the most reliable way to consolidate your understanding and build the clinical reasoning skills the MRCEM Primary tests. Visit EM Learning Centre for MRCEM Primary pathology revision questions and expert study resources to get started today.